Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Notes: A few simple reasons: Always ask what the price covers: the drug, the doctor visit, monitoring, and follow-up
Blair Murphy-Rose, MD, is a board-certified dermatologist in New York
A simple way to think about the current theoretical risk is: Lower theoretical concern: BPC-157 Moderate theoretical concern: TB-500 and thymosin beta-4 fragments Higher theoretical concern: GH/IGF-1-stimulating compounds, such as CJC-1295, ipamorelin, and MK-677 Not primarily a cancer concern: GLP-1 agonists, such as semaglutide, tirzepatide, and retatrutide, except in individuals with MEN2 or medullary thyroid cancer risk Does GHK-Cu cause copper toxicity
Abbreviations DPP-4: Dipeptidyl peptidase-4 GIP: Glucose-dependent insulinotropic polypeptide GLP-1: Glucagon-like peptide-1 IFG: Impaired fasting glucose IGT: Impaired glucose tolerance PYY: Peptide YY References Nauck M, Stckmann F, Ebert R, Creutzfeldt W (1986) Reduced incretin effect in type 2 (non-insulin-dependent) diabetes
